Acadia Pharmaceuticals buy Mizuho
Start price
28.02.24
/
50%
€21.60
Target price
28.02.25
€36.02
Performance (%)
-18.36%
Price
26.07.24
€17.64
Summary
This prediction is currently active. The prediction for Acadia Pharmaceuticals disappoints with a performance of -18.36%. This prediction currently runs until 28.02.25. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | 8.124% | 8.124% |
iShares Core DAX® | -0.598% | 0.645% |
iShares Nasdaq 100 | -3.290% | -4.193% |
iShares Nikkei 225® | -0.796% | -0.582% |
iShares S&P 500 | -1.164% | -0.857% |
Comments by Mizuho for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Mizuho from $40.00 to $39.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Mizuho for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
29.12.23
29.12.23
€36.19
29.12.24
29.12.24
-37.90%
26.07.24
26.07.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.40
06.11.23
06.11.23
€32.59
06.11.24
06.11.24
-21.27%
26.07.24
26.07.24